Some patients carry genetic variants that reduce how effectively their GLP-1 receptors respond to the medication, leading to what researchers call 'primary non-response.' Others develop tolerance as their bodies adapt to the drug over weeks or months, a phenomenon called 'tachyphylaxis.' Lifestyle factors also play a measurable role
Endocrinology (2000) 141:122835
Key takeaways: Rybelsus (semaglutide) is being phased out and replaced by a reformulated version, often called the Ozempic pill
For the first time ever, Gabby didnt need an afternoon nap to make it through the day and best yet, she could now keep up with her young kids
Barzegar S, Rezvani MR, Safa M, Amani A, Abbaspour A, Pourfathollah A, et al
If your nodules were deemed low-risk and follow-up was set for two years, maintain that schedule